Tembisa

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
Bactericidal Activity of TBD09 in Combination With Other Drugs in Pulmonary Tuberculosis	Drug Susceptible Pulmonary Tuberculosis	Recruiting	Phase 2	2026-07-30	NCT07525427
Safety and Tolerability of 1 Month Daily (1HP) and 3 Months Weekly (3HP) Isoniazid and Rifapentine With Pharmacokinetics of Dolutegravir (DTG) in Pregnant People With HIV	Actinomycetales infectious disease, Bacterial Infections and Mycoses, Blood-Borne Infections, Genital Diseases, HIV Seropositivity, HIV infectious disease, Infections, RNA Virus Infections, Urogenital Diseases, bacterial infectious disease, disease arising from reactivation of latent virus, gram-positive bacterial infections, immune system disorder, inborn error of immunity, infectious disease, latent tuberculosis infection, lentivirus infection, mycobacterial infectious disease, sexually transmitted disease, tuberculosis, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease	Active, not recruiting	Phase 1 / Phase 2	2025-12-12	NCT05122026
A Pan-TB Regimen Targeting Host and Microbe	Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, mycobacterial infectious disease, tuberculosis	Active, not recruiting	Phase 2 / Phase 3	2025-05-28	NCT05686356

Clinical trials